You may save and return to this form at any time - presenting author will receive an email to return to edit, and eventually upload PDF of poster if accepted.
The NASP Education Committee welcomes submission of original or encore research relevant to specialty pharmacy, outcomes related to specialty pharmacy products, or services provided by specialty pharmacies. Accepted abstracts will be presented at the 8th NASP Annual Meeting & Expo to be held September 14 - 18, 2020, and published online through the PubMed-indexed Journal of Drug Assessment.
All abstracts must be submitted online, using the template below, by July 17, 2020.
Submission GuidelinesYour abstract should be a short description of your research/work in specialty pharmacy, containing all the elements necessary to define your goals and results to the reader. Authors will be required to disclose all financial relationships through the online system, helping to ensure quality and unbiased presentations. Continuing education credits are not available for the posters.
Share your research or best practices with your peers. Categories of submission include:
Delivery of Specialty Pharmacy Products or ServicesAdherenceOutcomes (Cost or Other)Student ResearchCOVID-19 Products or ServicesNote: Abstract submissions must reflect completed research. Submissions of previously presented research are permitted.
The Education Committee will evaluate the abstracts based on the following criteria: novelty of the research, significance of the findings, relevance to specialty pharmacy, and clarity. Incomplete abstracts will not be accepted.
Notification of acceptance, or regret, will be delivered via email to the presenter(s) of each poster abstract by August 3, 2020.
If your abstract has been previously presented at, or published for, a conference/congress, please include this information at the end of your abstract as "Previous Presentation/Publication." No permission is needed for encore publication in the 8th NASP Annual Meeting & Expo 2020 Research Presentation Abstracts book.
If accepted for presentation, abstracts and posters will be available for viewing during the 8th NASP Annual Meeting & Expo. The posters will be displayed for the full duration of the meeting and announcement of the top posters will be made at the start of the general session on Wednesday morning, September 16, 2020. The presentation at the Annual Meeting must match the submitted abstract title, authorship, and content. Submission will also be published in the 8th NASP Annual Meeting & Expo 2020 Research Presentation Abstracts Book.
At least one author must register to attend the 8th NASP Annual Meeting & Expo, be identified on the abstract submission as the presenting author, and is required to present during the poster session.
Abstracts should be structured in such a way as to include the following 5 sections:
Background/Significance – What was the problem and why was it important? What knowledge are you building on?Objectives – What was the intent or goal of the study? What did you want to learn?Methods – What was the trial design? What was the sample? What instruments were used? How was data collected and analyzed?Results – What were the findings?Conclusions – What do the findings mean?
Tables, illustrations, and/or figures are not allowed and will be deleted if submitted.Abbreviations may be used if standard or if spelled out and defined at the first use (put in parentheses immediately after the first mention of a term or phrase). Compounds should be mentioned with the generic name, in lower cases. Commercial names may be included in the abstract text in parentheses with an ®, directly following the generic name at first use, i.e. "generic (Commercial ®)."
This Agreement is by and between the National Association of Specialty Pharmacy, Inc. (“NASP”) and the author(s) of the written paper, poster, or other submission identified above as the “Work” (individually and collectively, “you”) and concerns publication, presentation and distribution of the Work, including (without limitation) at the National Association of Specialty Pharmacy Annual Meeting & Educational Conference (“Conference”), and other use(s) by NASP as described more fully herein, including publication in an open access supplement of the Journal of Drug Assessment (“Supplement”).
1. Participation. By your signature below, you agree to prepare and submit a Work to NASP that is acceptable, in the sole judgment of NASP, for presentation at the Conference and publication and/or distribution by NASP. You agree to make such changes in the Work as NASP and/or the publisher of the Supplement (“Publisher”) may reasonably request prior to the Conference and/or publication in the Supplement. You further agree that NASP and/or the Publisher may revise the Work as necessary to conform to the formatting requirements for publication, and you agree to cooperate with NASP in connection with NASP’s use of the Work under this Agreement and consent to NASP’s use of your name, likeness and biographical information in connection with NASP’s use of the Work under this Agreement, with no additional right of approval over any such revisions or usage.
2. License. You hereby grant to NASP a non-exclusive, irrevocable, worldwide license to use, produce, publish, modify, create derivative works from, reproduce, distribute, and/or sublicense the Work, including but not limited to publication in the Supplement, and to do so in any and all media and formats, whether now known or later developed, throughout the world. This license is non-exclusive and does not prevent you from using or republishing the Work or related materials elsewhere.
3. Representations and Warranties. You represent and warrant that the Work is original and does not infringe the copyright or violate any other contractual or proprietary rights of any third party, that it contains no matter that is libelous or otherwise violates the personal rights of any third party, including but not limited to the rights of privacy and publicity; and that you have the authority to enter into this Agreement. You further represent and warrant that you have disclosed all relevant affiliations, financial sponsorships, and commercial assistance. You agree to indemnify and hold harmless NASP, the Publisher, and their officers, directors, employees, and agents, from and against any damages, liabilities, costs and expenses (including reasonable attorneys’ fees and court costs) to the extent they relate to your breach of a representation or warranty under this Agreement.
4. Miscellaneous. This Agreement will benefit and bind you and NASP, and our respective successors, assigns, and licensees. This Agreement contains the entire agreement between you and NASP on the subject matter hereof and supersedes any and all prior communications, representations, or agreements, verbal or written, relating to the subject matter. This Agreement may only be amended by a writing signed by both parties. Please sign and date this Agreement and return to NASP with submission of the application by no later than June 17, 2020. For multiple authors, please submit a duplicate of this page executed by each author.
Posters cannot exceed 4' tall and 8' wide. It must reflect the submitted abstract; i.e., abstract title, authorship, and content must match the submitted abstract.